StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued on Sunday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE stock opened at $0.00 on Friday. The business’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.06. The company has a market cap of $2,964.00, a PE ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.99.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.